EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses

Marie Royer iD, Nicolas Cabanel, Arnaud Gutierrez iD, Guilhem Royer iD, Olivier Barraud iD, Thierry Naas iD, Isabelle Rosinski-Chupin iD, Claude Loverdo iD, Philippe Glaser iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01207-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Marie Royer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ecology and Evolution of Antibiotic Resistance Unit, Institut Pasteur, CNRS UMR 6047 Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Amdinocillin, Anti-Bacterial Agents. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a silent pandemic responsible for 1.14 million deaths worldwide in 2021, with a major contribution from Klebsiella pneumoniae . β-lactams are the most commonly used antibiotics in humans, and there is an urgent need to characterize the resistance mechanisms to these antibiotics in Enterobacterales other than Escherichia coli . Mecillinam is a narrow-spectrum β-lactam targeting a single penicillin-binding protein, PBP2. Pivmecillinam, its oral prodrug, is used as a first-line treatment for uncomplicated urinary tract infections. It has been used for decades in Europe but was only authorized by the US Food and Drug Administration in 2024. Here, we decipher mecillinam resistance mechanisms in K. pneumoniae by characterizing its resistome in a pan-susceptible strain. The chromosomally encoded SHV β-lactamase led to spontaneous mecillinam-resistant mutants appearing at a higher rate, growing faster and at higher mecillinam concentrations in K. pneumoniae than in E. coli . The most frequent genetic event was an unstable duplication leading to heteroresistance. The selected mutations leading to resistance affected a wide range of functions, with resistance being dependent or independent of the RelA (p)ppGpp synthetase. Through an in-depth characterization of six mutant strains, we showed that, in the presence of mecillinam, they all experienced different growth defects despite high minimal inhibitory concentrations. Overall, our results in K. pneumoniae suggest different mechanisms to escape the complex mode of action of β-lactams in synergy with the β-lactamase SHV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAmdinocillinAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-Lactamasesbeta-Lactamsbeta Lactam AntibioticsEscherichia coliPenicillin-Binding ProteinsMutation

Stichwörter der Autor:innen

Klebsiella pneumoniaeantibiotic resistanceheteroresistancemecillinampenicillin-binding proteinβ-lactam

Substanzen

AmdinocillinAnti-Bacterial Agentsbeta-Lactamasesbeta-Lactamsbeta Lactam AntibioticsPenicillin-Binding Proteins

Autor:innen und Institutionen

  • Ecology and Evolution of Antibiotic Resistance Unit, Institut Pasteur, CNRS UMR 6047 Université Paris Cité, Paris, France.
  • Ecole doctorale complexité du vivant, Sorbonne Université, Paris, France.
  • Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.
  • Université Limoges, INSERM, CHU Limoges, UMR 1092, Limoges, France.
  • Team "RESIST," Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT/UMRS1184), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, Le Kremlin-Bicêtre, France.
  • Laboratoire Jean Perrin, Sorbonne Université, CNRS, Paris, France.

ORCID-Profile: Marie Royer, Arnaud Gutierrez, Guilhem Royer, Olivier Barraud, Thierry Naas, Isabelle Rosinski-Chupin, Claude Loverdo, Philippe Glaser

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Royer, M., Cabanel, N., Gutierrez, A., Royer, G., Barraud, O., Naas, T., Rosinski-Chupin, I., Loverdo, C., & Glaser, P. (2026). The mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01207-25

Vancouver

Royer M, Cabanel N, Gutierrez A, Royer G, Barraud O, Naas T, et al. The mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01207-25

BibTeX
@article{Royer2026,
  author = {Royer, Marie and Cabanel, Nicolas and Gutierrez, Arnaud and Royer, Guilhem and Barraud, Olivier and Naas, Thierry and Rosinski-Chupin, Isabelle and Loverdo, Claude and Glaser, Philippe},
  title = {The mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01207-25}
}
Kostenlos starten →